GW & Wade’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$709K Buy
1,515
+230
+18% +$108K 0.02% 261
2023
Q3
$566K Sell
1,285
-25
-2% -$11K 0.02% 261
2023
Q2
$597K Hold
1,310
0.02% 256
2023
Q1
$605K Sell
1,310
-17
-1% -$7.89K 0.02% 244
2022
Q4
$724K Buy
1,327
+16
+1% +$8.35K 0.03% 222
2022
Q3
$616K Sell
1,311
-2
-0.2% -$953 0.03% 221
2022
Q2
$628K Buy
1,313
+23
+2% +$10.6K 0.03% 227
2022
Q1
$577K Sell
1,290
-462
-26% -$191K 0.02% 229
2021
Q4
$678K Hold
1,752
0.03% 220
2021
Q3
$631K Sell
1,752
-10
-0.6% -$3.61K 0.03% 223
2021
Q2
$640K Buy
1,762
+272
+18% +$98K 0.03% 222
2021
Q1
$482K Buy
1,490
+823
+123% +$248K 0.03% 227
2020
Q4
$203K Sell
667
-986
-60% -$302K 0.01% 300
2020
Q3
$522K Buy
1,653
+4
+0.2% +$1.3K 0.04% 148
2020
Q2
$507K Buy
1,649
+8
+0.5% +$2.62K 0.04% 148
2020
Q1
$496K Buy
+1,641
New +$571K 0.05% 135
2016
Q1
Sell
-1,700
Closed -$321K 224
2015
Q4
$321K Buy
+1,700
New +$312K 0.07% 154

Other funds holding NOC

GW & Wade's NOC Position: Q4 2023 in Review

GW & Wade increased its Northrop Grumman (NOC) stake by 18% in Q4 2023, buying an estimated $108K and bringing the position to 1,515 shares worth $709K. The position accounts for 0.02% of the portfolio, ranked #261.

GW & Wade first reported a position in NOC in Q4 2015 and has held it in 17 quarters since. The position peaked at $724K in Q4 2022. 1,518 funds tracked by Wall St. Rank hold NOC as of Q4 2023.

  • GW & Wade held 1,515 shares of Northrop Grumman worth $709K as of Q4 2023.
  • GW & Wade bought 230 Northrop Grumman shares in Q4 2023, an estimated $108K.
  • Northrop Grumman made up 0.02% of GW & Wade's portfolio in Q4 2023, its #261 holding.
  • GW & Wade first reported a position in Northrop Grumman in Q4 2015 and has held it in 17 quarters since.
  • GW & Wade's Northrop Grumman position peaked at $724K in Q4 2022.
  • 1,518 funds tracked by Wall St. Rank held Northrop Grumman as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.